Linagliptin and Speech disorder - a phase IV clinical study of FDA data

Summary:

Speech disorder is reported as a side effect among people who take Linagliptin (linagliptin), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Metformin, and have Blood glucose abnormal.

The phase IV clinical study analyzes which people have Speech disorder when taking Linagliptin. It is created by eHealthMe based on reports of 8,096 people who have side effects when taking Linagliptin from the FDA, and is updated regularly.

What is Linagliptin?

Linagliptin has active ingredients of linagliptin. eHealthMe is studying from 8,112 Linagliptin users. Check the latest studies of Linagliptin.

What is Speech disorder?

Speech disorder is found to be associated with 1,803 drugs and 2,281 conditions by eHealthMe. Check the latest studies of Speech disorder.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

8,096 people reported to have side effects when taking Linagliptin.
Among them, 11 people (0.14%) have Speech disorder.

Could Linagliptin cause Speech disorder?

Among these 11 people:

How long have people been on Linagliptin when they have Speech disorder? *

What is the gender of people who have Speech disorder when taking Linagliptin? *

female: 100 %
male: 0.0 %

What is the age of people who have Speech disorder when taking Linagliptin? *

What are other drugs people take besides Linagliptin? *

What are other side effects people have besides Speech disorder? *

Movement Disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness): 5 people, 45.45%
Malaise (a feeling of general discomfort or uneasiness): 4 people, 36.36%
Fatigue (feeling of tiredness): 4 people, 36.36%
Tooth Disorder (tooth disease): 4 people, 36.36%
Tooth Abscess (pus formation in tooth): 4 people, 36.36%
Concussion (short loss of normal brain function in response to a head injury): 4 people, 36.36%
Diarrhea: 4 people, 36.36%
Oral Pain: 4 people, 36.36%
Lactic Acidosis (low ph in body tissues): 3 people, 27.27%
Weakness: 3 people, 27.27%

What are the existing conditions these people have? *

Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 4 people, 36.36%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 4 people, 36.36%
Blood Glucose Abnormal: 4 people, 36.36%
Back Pain: 3 people, 27.27%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 18.18%
Type 2 Diabetes: 1 person, 9.09%
Diabetes Mellitus Inadequate Control: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Linagliptin and have Speech disorder?

- Check whether Speech disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Linagliptin:

Linagliptin (8,112 reports)

Speech disorder treatments and more:

Speech disorder (62,574 reports)

Browse all side effects of Linagliptin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Speech disorder:

Speech disorder (1,803 drugs)

Browse all the conditions that are associated with Speech disorder:

Speech disorder (2,281 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on linagliptin (the active ingredients of Linagliptin) and Linagliptin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.